Geoffrey Thomas Yarranton
Plus aucun poste en cours
Historique de carrière de Geoffrey Thomas Yarranton
Anciens postes connus de Geoffrey Thomas Yarranton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celscia Therapeutics, Inc.
 Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Fondateur | 01/01/2004 | 01/01/2004 |
| President | - | 01/01/2004 | |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Directeur Technique/Scientifique/R&D | 02/10/2012 | - |
| Corporate Officer/Principal | - | 02/10/2012 | |
| DELTAGEN INC. | Corporate Officer/Principal | 01/05/2002 | - |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Corporate Officer/Principal | - | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - | - |
| HUMANIGEN, INC. | Directeur/Membre du Conseil | 01/10/2006 | 02/10/2012 |
| Directeur Technique/Scientifique/R&D | 01/10/2006 | - |
Formation de Geoffrey Thomas Yarranton
| University of Leicester | Undergraduate Degree |
| The National Institute For Medical Research | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Royaume-Uni | 4 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| DELTAGEN INC. | Commercial Services |
| Entreprise privées | 4 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Commercial Services |
- Bourse
- Insiders
- Geoffrey Thomas Yarranton
- Expérience
